• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

CD27是肿瘤坏死因子受体超家族的一员,通过TRAF2、TRAF5和NF-κB诱导激酶激活NF-κB和应激激活蛋白激酶/c-Jun N端激酶。

CD27, a member of the tumor necrosis factor receptor superfamily, activates NF-kappaB and stress-activated protein kinase/c-Jun N-terminal kinase via TRAF2, TRAF5, and NF-kappaB-inducing kinase.

作者信息

Akiba H, Nakano H, Nishinaka S, Shindo M, Kobata T, Atsuta M, Morimoto C, Ware C F, Malinin N L, Wallach D, Yagita H, Okumura K

机构信息

Department of Immunology, Juntendo University School of Medicine, 2-1-1 Hongo, Bunkyo-ku, Tokyo 113, Japan.

出版信息

J Biol Chem. 1998 May 22;273(21):13353-8. doi: 10.1074/jbc.273.21.13353.

DOI:10.1074/jbc.273.21.13353
PMID:9582383
Abstract

CD27 is a member of the tumor necrosis factor (TNF) receptor superfamily and is expressed on T, B, and NK cells. The signal via CD27 plays pivotal roles in T-T and T-B cell interactions. Here we demonstrate that overexpression of CD27 activates NF-kappaB and stress-activated protein kinase (SAPK)/c-Jun N-terminal kinase (JNK). Deletion analysis of the cytoplasmic domain of CD27 revealed that the C-terminal PIQEDYR motif was indispensable for both NF-kappaB and SAPK/JNK activation and was also required for the interaction with TNF receptor-associated factor (TRAF) 2 and TRAF5, both of which have been implicated in NF-kappaB activation by members of the TNF-R superfamily. Co-transfection of a dominant negative TRAF2 or TRAF5 blocked NF-kappaB and SAPK/JNK activation induced by CD27. Recently, a TRAF2-interacting kinase has been identified, termed NF-kappaB-inducing kinase (NIK). A kinase-inactive mutant NIK blocked CD27-, TRAF2-, and TRAF5-mediated NF-kappaB and SAPK/JNK activation. These results indicate that TRAF2 and TRAF5 are involved in NF-kappaB and SAPK/JNK activation by CD27, and NIK is a common downstream kinase of TRAF2 and TRAF5 for NF-kappaB and SAPK/JNK activation.

摘要

CD27是肿瘤坏死因子(TNF)受体超家族的成员,在T细胞、B细胞和NK细胞上表达。经由CD27的信号在T-T和T-B细胞相互作用中起关键作用。在此我们证明,CD27的过表达激活核因子κB(NF-κB)和应激激活蛋白激酶(SAPK)/c-Jun氨基末端激酶(JNK)。对CD27胞质结构域的缺失分析显示,C末端的PIQEDYR基序对于NF-κB和SAPK/JNK的激活都是必不可少的,并且也是与TNF受体相关因子(TRAF)2和TRAF5相互作用所必需的,这两者都与TNF-R超家族成员介导的NF-κB激活有关。共转染显性负性TRAF2或TRAF5可阻断CD27诱导的NF-κB和SAPK/JNK激活。最近,已鉴定出一种与TRAF2相互作用的激酶,称为NF-κB诱导激酶(NIK)。一种激酶失活的突变体NIK可阻断CD27、TRAF2和TRAF5介导的NF-κB和SAPK/JNK激活。这些结果表明,TRAF2和TRAF5参与了CD27介导的NF-κB和SAPK/JNK激活,并且NIK是TRAF2和TRAF5在NF-κB和SAPK/JNK激活过程中的共同下游激酶。

相似文献

1
CD27, a member of the tumor necrosis factor receptor superfamily, activates NF-kappaB and stress-activated protein kinase/c-Jun N-terminal kinase via TRAF2, TRAF5, and NF-kappaB-inducing kinase.CD27是肿瘤坏死因子受体超家族的一员,通过TRAF2、TRAF5和NF-κB诱导激酶激活NF-κB和应激激活蛋白激酶/c-Jun N端激酶。
J Biol Chem. 1998 May 22;273(21):13353-8. doi: 10.1074/jbc.273.21.13353.
2
Activation of NF-kappaB by RANK requires tumor necrosis factor receptor-associated factor (TRAF) 6 and NF-kappaB-inducing kinase. Identification of a novel TRAF6 interaction motif.RANK对核因子κB(NF-κB)的激活需要肿瘤坏死因子受体相关因子(TRAF)6和NF-κB诱导激酶。一种新型TRAF6相互作用基序的鉴定。
J Biol Chem. 1999 Mar 19;274(12):7724-31. doi: 10.1074/jbc.274.12.7724.
3
Tumor necrosis factor (TNF) receptor 1 signaling downstream of TNF receptor-associated factor 2. Nuclear factor kappaB (NFkappaB)-inducing kinase requirement for activation of activating protein 1 and NFkappaB but not of c-Jun N-terminal kinase/stress-activated protein kinase.肿瘤坏死因子(TNF)受体相关因子2下游的肿瘤坏死因子(TNF)受体1信号传导。激活蛋白1和核因子κB(NFκB)激活对核因子κB诱导激酶的需求,但对c-Jun氨基末端激酶/应激激活蛋白激酶的激活无此需求。
J Biol Chem. 1997 Oct 17;272(42):26079-82. doi: 10.1074/jbc.272.42.26079.
4
Activation of stress-activated protein kinase/c-Jun N-terminal kinase, but not NF-kappaB, by the tumor necrosis factor (TNF) receptor 1 through a TNF receptor-associated factor 2- and germinal center kinase related-dependent pathway.肿瘤坏死因子(TNF)受体1通过肿瘤坏死因子受体相关因子2和生发中心激酶相关依赖途径激活应激激活蛋白激酶/c-Jun氨基末端激酶,但不激活核因子κB。
J Biol Chem. 1997 Dec 19;272(51):32102-7. doi: 10.1074/jbc.272.51.32102.
5
Epstein-Barr virus-encoded latent membrane protein 1 activates the JNK pathway through its extreme C terminus via a mechanism involving TRADD and TRAF2.爱泼斯坦-巴尔病毒编码的潜伏膜蛋白1通过一种涉及TRADD和TRAF2的机制,经由其极端的C末端激活JNK途径。
J Virol. 1999 Feb;73(2):1023-35. doi: 10.1128/JVI.73.2.1023-1035.1999.
6
Differential requirements for tumor necrosis factor receptor-associated factor family proteins in CD40-mediated induction of NF-kappaB and Jun N-terminal kinase activation.肿瘤坏死因子受体相关因子家族蛋白在CD40介导的核因子κB诱导及Jun N端激酶激活中的差异需求
J Biol Chem. 1999 Aug 6;274(32):22414-22. doi: 10.1074/jbc.274.32.22414.
7
Tumor necrosis factor (TNF)-mediated kinase cascades: bifurcation of nuclear factor-kappaB and c-jun N-terminal kinase (JNK/SAPK) pathways at TNF receptor-associated factor 2.肿瘤坏死因子(TNF)介导的激酶级联反应:在肿瘤坏死因子受体相关因子2处核因子-κB和c-Jun氨基末端激酶(JNK/SAPK)途径的分支
Proc Natl Acad Sci U S A. 1997 Sep 2;94(18):9792-6. doi: 10.1073/pnas.94.18.9792.
8
ASK1 is essential for JNK/SAPK activation by TRAF2.ASK1对于TRAF2激活JNK/SAPK至关重要。
Mol Cell. 1998 Sep;2(3):389-95. doi: 10.1016/s1097-2765(00)80283-x.
9
TNF-mediated activation of the stress-activated protein kinase pathway: TNF receptor-associated factor 2 recruits and activates germinal center kinase related.肿瘤坏死因子介导的应激激活蛋白激酶途径的激活:肿瘤坏死因子受体相关因子2招募并激活生发中心激酶相关蛋白。
J Immunol. 1999 Sep 15;163(6):3279-85.
10
Receptor activator of NF-kappaB recruits multiple TRAF family adaptors and activates c-Jun N-terminal kinase.核因子κB受体激活剂招募多种肿瘤坏死因子受体相关因子家族衔接蛋白并激活c-Jun氨基末端激酶。
FEBS Lett. 1999 Jan 29;443(3):297-302. doi: 10.1016/s0014-5793(98)01731-1.

引用本文的文献

1
The Relationship and Mechanism of CD27 with Coronary Atherosclerotic Heart Disease.CD27与冠状动脉粥样硬化性心脏病的关系及机制
Cardiovasc Drugs Ther. 2025 Aug 8. doi: 10.1007/s10557-025-07740-y.
2
Enhancing Fc-mediated effector functions of monoclonal antibodies: The example of HexaBodies.增强单克隆抗体的Fc介导效应功能:六聚体的实例
Immunol Rev. 2024 Nov;328(1):456-465. doi: 10.1111/imr.13394. Epub 2024 Sep 14.
3
Azithromycin targets the CD27 pathway to modulate CD27hi T-lymphocyte expansion and type-1 effector phenotype.
阿奇霉素靶向 CD27 通路调节 CD27hiT 淋巴细胞扩增和 1 型效应表型。
Front Immunol. 2024 Aug 15;15:1447625. doi: 10.3389/fimmu.2024.1447625. eCollection 2024.
4
Friend or Foe - Tc17 cell generation and current evidence for their importance in human disease.敌友之间——Tc17细胞的产生及其在人类疾病中重要性的现有证据
Discov Immunol. 2023 Jul 20;2(1):kyad010. doi: 10.1093/discim/kyad010. eCollection 2023.
5
Signaling via a CD27-TRAF2-SHP-1 axis during naive T cell activation promotes memory-associated gene regulatory networks.在初始 T 细胞激活过程中通过 CD27-TRAF2-SHP-1 轴进行信号传递可促进与记忆相关的基因调控网络。
Immunity. 2024 Feb 13;57(2):287-302.e12. doi: 10.1016/j.immuni.2024.01.011.
6
The novel high-affinity humanized antibody IMM40H targets CD70, eliminates tumors via Fc-mediated effector functions, and interrupts CD70/CD27 signaling.新型高亲和力人源化抗体IMM40H靶向CD70,通过Fc介导的效应功能消除肿瘤,并中断CD70/CD27信号传导。
Front Oncol. 2023 Oct 2;13:1240061. doi: 10.3389/fonc.2023.1240061. eCollection 2023.
7
Chronic CD27-CD70 costimulation promotes type 1-specific polarization of effector Tregs.慢性 CD27-CD70 共刺激促进效应性 Treg 的 1 型特异性极化。
Front Immunol. 2023 Mar 13;14:1023064. doi: 10.3389/fimmu.2023.1023064. eCollection 2023.
8
SMAC mimetics inhibit human T cell proliferation and fail to augment type 1 cytokine responses.SMAC 模拟物抑制人 T 细胞增殖,并且不能增强 1 型细胞因子应答。
Cell Immunol. 2023 Feb;384:104674. doi: 10.1016/j.cellimm.2023.104674. Epub 2023 Jan 18.
9
The role of immune profile in predicting outcomes in cancer patients treated with immunotherapy.免疫特征在预测免疫治疗癌症患者结局中的作用。
Front Immunol. 2022 Nov 3;13:974087. doi: 10.3389/fimmu.2022.974087. eCollection 2022.
10
Cytomegalovirus infection reduced CD70 expression, signaling and expansion of viral specific memory CD8 T cells in healthy human adults.巨细胞病毒感染降低了健康成年人中病毒特异性记忆CD8 T细胞的CD70表达、信号传导及扩增。
Immun Ageing. 2022 Nov 11;19(1):54. doi: 10.1186/s12979-022-00307-7.